Superworth

Tenax Therapeutics EPS TENX

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$1.48
Latest quarter, Q2 FY26
−$0.35
Fiscal year 2025
−$1.33

Tenax Therapeutics' earnings per share was −$1.48 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.35.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.33n/a
FY2024−$5.31−116%
FY2023$33.52n/a
FY2022−$597.60n/a
FY2021−$6944.00n/a
FY2019−$4832.00n/a
FY2018−$26848.00n/a
FY2017−$27024.00−154%
FY2016$49920.00n/a
FY2015n/an/a
FY2014−$98240.00n/a
FY2013−$264320.00n/a
FY2012−$595200.00n/a
FY2011−$134400.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.35n/a−$1.48
Q1 FY26−$0.35n/a−$1.40
Q4 FY25−$0.38n/a−$1.33
Q3 FY25−$0.40n/a−$1.12
Q2 FY25−$0.27n/a−$0.91
Q1 FY25−$0.28n/a−$2.47
Q4 FY24−$0.17−102%−$5.31
Q3 FY24−$0.19−103%$5.67
Q2 FY24−$1.83−146%$12.47
Q1 FY24−$3.12−126%$18.30
Q4 FY23$10.81n/a$33.52
Q3 FY23$6.61−96%−$743.69

Against its peers

Companies in Drug Manufacturers - General nearest Tenax Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
TENXTenax Therapeutics−$1.48
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
Peer median$0.52

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Tenax Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.